Assignee
ACUMEN PHARMACEUTICALS INC
US·3 granted patents·3 pending applications·2 citations·filing 2007–2015
Top patents by PatentIndex Score
6 records- 0165US9320793B2Method for treating a disease associated with soluble, oligomeric species of amyloid beta 1-42ACUMEN PHARMACEUTICALS INC·Filed 2012·Granted Apr 26, 2016·1 cites·1 claims
- 0264US9310383B2Antibodies, kit and method for detecting amyloid beta oligomersACUMEN PHARMACEUTICALS INC·Filed 2015·Granted Apr 12, 2016·1 cites·8 claims
- 0352US7964359B2Compositions and methods for the enhancement of soluble amyloid beta oligomer (ADDL) uptake and clearanceACUMEN PHARMACEUTICALS INC·Filed 2007·Granted Jun 21, 2011·0 cites·2 claims
- 0452US2011098309A1Methods of inhibiting the formation of amyloid-beta diffusable ligands using acylhydrazide compoundsACUMEN PHARMACEUTICALS INC·Filed 2008·Application pending·0 cites
- 0547US2015320860A1Method for treating a disease associated with soluble, oligomeric species of amyloid beta 1-42ACUMEN PHARMACEUTICALS INC·Filed 2013·Application pending·0 cites
- 0646US2013330837A1Monoclonal antibodies that target pathological assemblies of amyloid beta (abeta)ACUMEN PHARMACEUTICALS INC·Filed 2013·Application pending·0 cites
Counts cover granted patents and pending applications in the PatentIndex corpus. How scoring works →